306 related articles for article (PubMed ID: 37265798)
1. Gas6/AXL pathway: immunological landscape and therapeutic potential.
Zhai X; Pu D; Wang R; Zhang J; Lin Y; Wang Y; Zhai N; Peng X; Zhou Q; Li L
Front Oncol; 2023; 13():1121130. PubMed ID: 37265798
[TBL] [Abstract][Full Text] [Related]
2. Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment.
Tanaka M; Siemann DW
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660000
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
Tanaka M; Siemann DW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576116
[TBL] [Abstract][Full Text] [Related]
4. Immune Evasion Mechanism and AXL.
Son HY; Jeong HK
Front Oncol; 2021; 11():756225. PubMed ID: 34778071
[TBL] [Abstract][Full Text] [Related]
5. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
Yan S; Vandewalle N; De Beule N; Faict S; Maes K; De Bruyne E; Menu E; Vanderkerken K; De Veirman K
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694201
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
[TBL] [Abstract][Full Text] [Related]
7. Targeting Gas6/TAM in cancer cells and tumor microenvironment.
Wu G; Ma Z; Cheng Y; Hu W; Deng C; Jiang S; Li T; Chen F; Yang Y
Mol Cancer; 2018 Jan; 17(1):20. PubMed ID: 29386018
[TBL] [Abstract][Full Text] [Related]
8. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance.
Baumann C; Ullrich A; Torka R
Mol Oncol; 2017 Oct; 11(10):1430-1447. PubMed ID: 28675785
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway.
Lee CH; Liu SY; Chou KC; Yeh CT; Shiah SG; Huang RY; Cheng JC; Yen CY; Shieh YS
Ann Surg Oncol; 2014 Mar; 21(3):1031-7. PubMed ID: 24276640
[TBL] [Abstract][Full Text] [Related]
10. Molecular insights of Gas6/TAM in cancer development and therapy.
Wu G; Ma Z; Hu W; Wang D; Gong B; Fan C; Jiang S; Li T; Gao J; Yang Y
Cell Death Dis; 2017 Mar; 8(3):e2700. PubMed ID: 28333143
[TBL] [Abstract][Full Text] [Related]
11. Gas6 Inhibits Toll-Like Receptor-Mediated Inflammatory Pathways in Mouse Microglia
Gilchrist SE; Goudarzi S; Hafizi S
Front Cell Neurosci; 2020; 14():576650. PubMed ID: 33192322
[No Abstract] [Full Text] [Related]
12. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
13. Immunological role of Gas6/TAM signaling in hemostasis and thrombosis.
Li F; Xu L; Li C; Hu F; Su Y
Thromb Res; 2024 Jun; 238():161-171. PubMed ID: 38723521
[TBL] [Abstract][Full Text] [Related]
14. A novel human anti-AXL monoclonal antibody attenuates tumour cell migration.
Duan Y; Luo L; Qiao C; Li X; Wang J; Liu H; Zhou T; Shen B; Lv M; Feng J
Scand J Immunol; 2019 Aug; 90(2):e12777. PubMed ID: 31075180
[TBL] [Abstract][Full Text] [Related]
15. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
[TBL] [Abstract][Full Text] [Related]
16. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
Sawabu T; Seno H; Kawashima T; Fukuda A; Uenoyama Y; Kawada M; Kanda N; Sekikawa A; Fukui H; Yanagita M; Yoshibayashi H; Satoh S; Sakai Y; Nakano T; Chiba T
Mol Carcinog; 2007 Feb; 46(2):155-64. PubMed ID: 17186543
[TBL] [Abstract][Full Text] [Related]
18. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.
Zhu C; Wei Y; Wei X
Mol Cancer; 2019 Nov; 18(1):153. PubMed ID: 31684958
[TBL] [Abstract][Full Text] [Related]
19. The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation.
Melchionna R; Spada S; Di Modugno F; D'Andrea D; Di Carlo A; Panetta M; Mileo AM; Sperduti I; Antoniani B; Gallo E; Lawlor RT; Piemonti L; Visca P; Milella M; Grazi GL; Facciolo F; Chen E; Scarpa A; Nisticò P
EMBO Rep; 2020 Nov; 21(11):e50078. PubMed ID: 32909687
[TBL] [Abstract][Full Text] [Related]
20. Endocytic trafficking of GAS6-AXL complexes is associated with sustained AKT activation.
Poświata A; Kozik K; Miączyńska M; Zdżalik-Bielecka D
Cell Mol Life Sci; 2022 May; 79(6):316. PubMed ID: 35622156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]